Search Results - "Heideman, Danielle A M"

Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older by Meijer, Chris J.L.M., Berkhof, Johannes, Castle, Philip E., Hesselink, Albertus T., Franco, Eduardo L., Ronco, Guglielmo, Arbyn, Marc, Bosch, F. Xavier, Cuzick, Jack, Dillner, Joakim, Heideman, Daniëlle A.M., Snijders, Peter J.F.

“…Given the strong etiologic link between high‐risk HPV infection and cervical cancer high‐risk HPV testing is now being considered as an alternative for…”
Get full text

Evaluation of 14 triage strategies for HPV DNA-positive women in population-based cervical screening by Rijkaart, Dorien C., Berkhof, Johannes, van Kemenade, Folkert J., Coupe, Veerle M.H., Hesselink, Albertus T., Rozendaal, Lawrence, Heideman, Danielle A.M., Verheijen, Ren H., Bulk, Saskia, Verweij, Wim M., Snijders, Peter J.F., Meijer, Chris J.L.M.

“…High‐risk human papillomavirus (hrHPV) testing has a higher sensitivity but lower specificity than cytology for detection of high‐grade intraepithelial…”
Get full text

Mismatch repair status and BRAF mutation status in metastatic colorectal cancer patients: a pooled analysis of the CAIRO, CAIRO2, COIN, and FOCUS studies by Venderbosch, Sabine, Nagtegaal, Iris D, Maughan, Tim S, Smith, Christopher G, Cheadle, Jeremy P, Fisher, David, Kaplan, Richard, Quirke, Philip, Seymour, Matthew T, Richman, Susan D, Meijer, Gerrit A, Ylstra, Bauke, Heideman, Danielle A M, de Haan, Anton F J, Punt, Cornelis J A, Koopman, Miriam

“…To determine the prevalence and prognostic value of mismatch repair (MMR) status and its relation to BRAF mutation (BRAF(MT)) status in metastatic colorectal…”
Get full text

Patients with penile cancer and the risk of (pre)malignant cervical lesions in female partners: a retrospective cohort analysis by Bruijn, Roderick E., Heideman, Danielle A.M., Kenter, Gemma G., Beurden, Marc, Tinteren, Harm, Horenblas, Simon

“…Objective To determine if female partners of patients with penile cancer have more cervical lesions and neoplasia than would be expected from population‐based…”
Get full text

Risk of cervical precancer among HPV–negative women in the Netherlands and its association with previous HPV and cytology results: A follow-up analysis of a randomized screening study by Inturrisi, Federica, Rozendaal, Lawrence, Veldhuijzen, Nienke J, Heideman, Daniëlle A. M, Meijer, Chris J. L. M, Berkhof, Johannes

“…Background Human papillomavirus (HPV)-based screening programs still use one-size-fits-all protocols but efficiency and efficacy of programs may be improved by…”
Get full text

A Phase II Study of Sorafenib in Patients with Platinum-Pretreated, Advanced (Stage IIIb or IV) Non―Small Cell Lung Cancer with a KRAS Mutation by DINGEMANS, Anne-Marie C, MELLEMA, Wouter W, GROEN, Harry J. M, WIJK, Atie Van, BURGERS, Sjaak A, KUNST, Peter W. A, THUNNISSEN, Erik, HEIDEMAN, Danielle A. M, SMIT, Egbert F

“…Sorafenib inhibits the Ras/Raf pathway, which is overactive in cancer patients with a KRAS mutation. We hypothesized that patients with non-small cell lung…”
Get full text

Clinical implications of (epi)genetic changes in HPV-induced cervical precancerous lesions by Steenbergen, Renske D. M., Snijders, Peter J. F., Heideman, Daniëlle A. M., Meijer, Chris J. L. M.

“…Key Points Cervical intraepithelial neoplasia (CIN) lesions can be divided into productive (CIN1 and CIN2) and transforming (CIN2 and CIN3) lesions…”
Get full text

Identification and Validation of a 3-Gene Methylation Classifier for HPV-Based Cervical Screening on Self-Samples by Verlaat, Wina, Snoek, Barbara C, Heideman, Daniëlle A M, Wilting, Saskia M, Snijders, Peter J F, Novianti, Putri W, van Splunter, Annina P, Peeters, Carel F W, van Trommel, Nienke E, Massuger, Leon F A G, Bekkers, Ruud L M, Melchers, Willem J G, van Kemenade, Folkert J, Berkhof, Johannes, van de Wiel, Mark A, Meijer, Chris J L M, Steenbergen, Renske D M

“…Offering self-sampling of cervico-vaginal material for high-risk human papillomavirus (hrHPV) testing is an effective method to increase the coverage in…”
Get full text

Risk-stratification of HPV-positive women with low-grade cytology by FAM19A4/miR124-2 methylation and HPV genotyping by Dick, Stèfanie, Vink, Frederique J., Heideman, Daniëlle A. M., Lissenberg-Witte, Birgit I., Meijer, Chris J. L. M., Berkhof, Johannes

“…Background The introduction of primary HPV screening has doubled the number of colposcopy referrals because of the direct referral of HPV-positive women with a…”
Get full text

Combination of NK Cells and Cetuximab to Enhance Anti-Tumor Responses in RAS Mutant Metastatic Colorectal Cancer by Veluchamy, John Pradeep, Spanholtz, Jan, Tordoir, Marleen, Thijssen, Victor L, Heideman, Daniëlle A M, Verheul, Henk M W, de Gruijl, Tanja D, van der Vliet, Hans J

“…The ability of Natural Killer (NK) cells to kill tumor targets has been extensively studied in various hematological malignancies. However, NK cell therapy…”
Get full text

Development of [11C]erlotinib Positron Emission Tomography for In Vivo Evaluation of EGF Receptor Mutational Status by BAHCE, Idris, SMIT, Egbert F, LAMMERTSMA, Adriaan A, HARRY HENDRIKSE, N, LUBBERINK, Mark, VAN DER VELDT, Astrid A. M, YAQUB, Maqsood, WINDHORST, Albert D, SCHUIT, Robert C, THUNNISSEN, Erik, HEIDEMAN, Daniëlle A. M, POSTMUS, Pieter E

“…To evaluate whether, in patients with non-small cell lung carcinoma (NSCLC), tumor uptake of [(11)C]erlotinib can be quantified and imaged using positron…”
Get full text

High‐risk human papillomavirus distribution according to human immunodeficiency virus status among women with cervical cancer in Abidjan, Côte d'Ivoire, 2018 to 2020 by Boni, Simon P., Tenet, Vanessa, Horo, Apollinaire, Heideman, Daniëlle A. M., Bleeker, Maaike C. G., Tanon, Aristophane, Mian, Boston, Mohenou, Isidore D., Ekouevi, Didier K., Gheit, Tarik, Didi‐Kouko Coulibaly, Judith, Tchounga, Boris K., Adoubi, Innocent, Clifford, Gary M., Jaquet, Antoine

“…As human papillomavirus (HPV) immunisation and HPV‐based cervical cancer (CC) screening programmes expand across sub‐Saharan Africa, we investigated the…”
Get full text

High‐risk HPV testing on self‐sampled versus clinician‐collected specimens: A review on the clinical accuracy and impact on population attendance in cervical cancer screening by Snijders, Peter J.F., Verhoef, Viola M.J., Arbyn, Marc, Ogilvie, Gina, Minozzi, Silvia, Banzi, Rita, van Kemenade, Folkert J., Heideman, Daniëlle A.M., Meijer, Chris J.L.M.

“…This review elaborates on the accuracy and feasibility of human papillomavirus (HPV) self‐sampling, i.e., offering self‐sampling of (cervico‐)vaginal cell…”
Get full text

Evaluation of DNA methylation biomarkers ASCL1 and LHX8 on HPV-positive self-collected samples from primary HPV-based screening by Verhoef, Lisanne, Bleeker, Maaike C. G., Polman, Nicole, Steenbergen, Renske D. M., Ebisch, Renée M. F., Melchers, Willem J. G., Bekkers, Ruud L. M., Molijn, Anco C., Quint, Wim G., van Kemenade, Folkert, Meijer, Chris J. L. M., Berkhof, Johannes, Heideman, Daniëlle A. M.

“…Background Host-cell DNA methylation analysis can be used to triage women with high-risk human papillomavirus (HPV)-positive self-collected cervicovaginal…”
Get full text

Population-based age- and type-specific prevalence of human papillomavirus among non-vaccinated women aged 30 years and above in Germany by Liang, Linda A, Tanaka, Luana F, Radde, Kathrin, Bussas, Ulrike, Ikenberg, Hans, Heideman, Daniëlle A M, Meijer, Chris J L M, Blettner, Maria, Klug, Stefanie J

“…A persisting high-risk human papillomavirus (HR-HPV) infection is causal for cervical cancer; however, there is limited population-based data on the prevalence…”
Get full text

Cervical cancer detection by DNA methylation analysis in urine by Snoek, Barbara C., Splunter, Annina P. van, Bleeker, Maaike C. G., Ruiten, Maartje C. van, Heideman, Daniëlle A. M., Rurup, W. Frederik, Verlaat, Wina, Schotman, Hans, Gent, Mignon van, Trommel, Nienke E. van, Steenbergen, Renske D. M.

“…Urine samples provide a potential alternative to physician-taken or self-collected cervical samples for cervical screening. Screening by primary hrHPV testing…”
Get full text

Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial by Rijkaart, Dorien C, MD, Berkhof, Johannes, PhD, Rozendaal, Lawrence, MD, van Kemenade, Folkert J, MD, Bulkmans, Nicole WJ, MD, Heideman, Daniëlle AM, PhD, Kenter, Gemma G, Prof, Cuzick, Jack, Prof, Snijders, Peter JF, Prof, Meijer, Chris JLM, Prof

“…Summary Background Human papillomavirus (HPV) testing is more sensitive for the detection of high-grade cervical lesions than is cytology, but detection of HPV…”
Get full text

Increasing prevalence rates of HPV attributable oropharyngeal squamous cell carcinomas in the Netherlands as assessed by a validated test algorithm by Rietbergen, Michelle M., Leemans, C. René, Bloemena, Elisabeth, Heideman, Daniëlle A.M., Braakhuis, Boudewijn J.M., Hesselink, Albertus T., Witte, Birgit I., de Jong, Robert J. Baatenburg, Meijer, Chris J.L.M., Snijders, Peter J.F., Brakenhoff, Ruud H.

“…Human papillomavirus (HPV) infection has been etiologically linked to oropharyngeal squamous cell carcinoma (OPSCC). The prevalence of HPV‐positive OPSCC…”
Get full text

Molecular characterization of p16‐immunopositive but HPV DNA‐negative oropharyngeal carcinomas by Rietbergen, Michelle M., Snijders, Peter J.F., Beekzada, Derakshan, Braakhuis, Boudewijn J.M., Brink, Arjen, Heideman, Daniëlle A.M., Hesselink, Albertus T., Witte, Birgit I., Bloemena, Elisabeth, Baatenburg‐De Jong, Robert J., René Leemans, C., Brakenhoff, Ruud H.

“…Recent studies have reported that p16 protein overexpression qualifies as a surrogate marker identifying an oncogenic human papillomavirus (HPV) infection in…”
Get full text

Host-cell DNA methylation patterns during high-risk HPV-induced carcinogenesis reveal a heterogeneous nature of cervical pre-cancer by Verlaat, Wina, Van Leeuwen, Robert W., Novianti, Putri W., Schuuring, Ed, Meijer, Chris J. L. M., Van Der Zee, Ate G. J., Snijders, Peter J. F., Heideman, Daniëlle A. M., Steenbergen, Renske D. M., Wisman, G. Bea A.

“…Cervical cancer development following a persistent infection with high-risk human papillomavirus (hrHPV) is driven by additional host-cell changes, such as…”
Get full text